DV125 (Divalproex Sodium Delayed-Release 125 mg)
Pill with imprint DV125 is Pink, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Genpharm Inc..
Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; cyclothymic disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DV125
Divalproex Sodium Delayed-Release
- Imprint:
- DV125
- Strength:
- 125 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine - CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Genpharm Inc.
- National Drug Code (NDC):
More about divalproex sodium
- Divalproex sodium Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 337 Reviews
- Drug class: fatty acid derivative anticonvulsants
Consumer resources
- Divalproex sodium
- Divalproex Long-Acting Tablets
- Divalproex Sprinkle Capsules
- Divalproex sodium (Advanced Reading)
Other brands: Depakote, Depakote ER, Depakote Sprinkles
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
